mci 9038 has been researched along with Ischemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, H; Ishibashi, A; Yoshitake, Y | 1 |
| Maldonado, A | 1 |
| Böhm, M; Link, A; Pöss, J | 1 |
| Honda, Y; Katsuta, H; Kiryu, J; Miyahara, S; Miyamoto, K; Nishijima, K; Nonaka, A; Tsujikawa, A; Yamashiro, K | 1 |
| Warkentin, TE | 1 |
| Bartholomew, JR | 1 |
| Beyer, J; Halbritter, K; Leonhard, J; Schellong, S; Weise, M | 1 |
2 review(s) available for mci 9038 and Ischemia
| Article | Year |
|---|---|
Heparin-induced thrombocytopenia: diagnosis and management.
Topics: Anticoagulants; Aortic Valve Insufficiency; Arginine; Autoantibodies; Autoimmune Diseases; Female; Fingers; Heart Valve Prosthesis Implantation; Heparin; Hirudins; Humans; Ischemia; Middle Aged; Necrosis; Pipecolic Acids; Platelet Activation; Platelet Factor 4; Postoperative Complications; Raynaud Disease; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Toes; Warfarin | 2004 |
Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
Topics: Administration, Oral; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Factors; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Hirudins; Humans; Ischemia; Leg; Necrosis; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2005 |
5 other study(ies) available for mci 9038 and Ischemia
| Article | Year |
|---|---|
Investigation of effect of edaravone on ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Antipyrine; Arginine; Edaravone; Female; Free Radical Scavengers; Humans; Ischemia; Male; Methacrylates; Middle Aged; Pipecolic Acids; Retrospective Studies; Risk Factors; Stroke; Sulfonamides; Young Adult | 2013 |
Argatroban and catheter-directed thrombolysis with alteplase for limb- and graft-threatening thromboses in a patient with a history of HIT.
Topics: Aged; Antibodies, Anticardiolipin; Anticoagulants; Arginine; Catheterization; Contraindications; Drug Therapy, Combination; Femoral Vein; Heparin; Humans; Iliac Vein; Infusions, Intravenous; Ischemia; Kidney; Kidney Transplantation; Male; Pipecolic Acids; Popliteal Vein; Postoperative Complications; Protein S Deficiency; Purpura, Thrombocytopenic, Idiopathic; Renal Veins; Sulfonamides; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator; Vena Cava Filters; Venous Thrombosis; Warfarin | 2009 |
[Diagnosis and treatment of heparin-induced thrombocytopenia].
Topics: Acute Kidney Injury; Aged; Anticoagulants; Antithrombins; Aortic Valve Stenosis; Arginine; Diagnosis, Differential; Hand; Heparin; Humans; Ischemia; Male; Pipecolic Acids; Platelet Count; Renal Dialysis; Shock, Cardiogenic; Sulfonamides; Thrombocytopenia; Ventricular Dysfunction, Left | 2011 |
Argatroban attenuates leukocyte- and platelet-endothelial cell interactions after transient retinal ischemia.
Topics: Animals; Arginine; Blood Platelets; Cell Adhesion; Disease Models, Animal; Endothelium, Vascular; Gene Expression; Intercellular Adhesion Molecule-1; Ischemia; Leukocytes; Male; P-Selectin; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Prothrombin Time; Rats; Rats, Long-Evans; Reperfusion; Retina; Retinal Diseases; Retinal Vessels; RNA, Messenger; Sulfonamides; Thrombin; Treatment Outcome; Vascular Patency | 2003 |
Heparin-induced thrombocytopenia II-induced critical limb ischaemia treated with urokinase and argatroban.
Topics: Aged; Arginine; Blood Coagulation Tests; Extremities; Heparin; Humans; Ischemia; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator | 2007 |